ATHE
Alterity Therapeutics Ltd
NASDAQ: ATHE · HEALTHCARE · BIOTECHNOLOGY
$4.83
-2.52% today
Updated 2026-06-01
Market cap
$88.31M
P/E ratio
—
P/S ratio
13.31x
EPS (TTM)
$-0.60
Dividend yield
—
52W range
$3 – $7
Volume
0.0M
Alterity Therapeutics Ltd (ATHE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-219.90%
Operating margin
-372.60%
ROE
-46.43%
ROA
-32.50%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $762486.00 | $-11.73M | 100.00% | -1,496.86% | -1,537.92% |
| 2007 | $507044.00 | $-11.14M | 100.00% | -2,167.55% | -2,197.05% |
| 2008 | $491997.00 | $-13.59M | 100.00% | -2,588.19% | -2,762.17% |
| 2009 | $428193.00 | $-7.52M | 100.00% | -1,935.69% | -1,756.87% |
| 2010 | $215008.00 | $-4.91M | 100.00% | -2,279.38% | -2,282.20% |
| 2011 | $156135.00 | $-6.43M | -155.70% | -4,020.25% | -4,118.99% |
| 2012 | $186664.00 | $-5.24M | 100.00% | -2,849.27% | -2,806.90% |
| 2013 | $150867.00 | $-7.79M | 2,975.15% | -5,171.41% | -5,161.66% |
| 2014 | $363775.00 | $-13.33M | 2,256.66% | -3,450.60% | -3,664.14% |
| 2015 | $176842.00 | $-5.89M | -45.50% | -5,901.05% | -3,327.87% |
| 2016 | $142657.00 | $-7.73M | 84.01% | -6,019.19% | -5,418.28% |
| 2017 | $132396.00 | $-7.54M | 83.89% | -5,197.94% | -5,696.60% |
| 2018 | $201174.00 | $-8.27M | 89.16% | -3,862.48% | -4,108.75% |
| 2019 | $108538.00 | $-11.96M | 72.64% | -11,713.74% | -11,020.84% |
| 2020 | $411567.00 | $-10.06M | -27.32% | -2,530.33% | -2,444.24% |
| 2021 | $4.34M | $-15.31M | 91.70% | -349.77% | -352.78% |
| 2022 | $5.12M | $-12.85M | 92.88% | -302.56% | -250.75% |
| 2023 | $3.92M | $-13.81M | 92.72% | -373.72% | -352.54% |
| 2024 | $4.02M | $-19.12M | 94.67% | -487.69% | -475.79% |
| 2025 | $5.44M | $-12.15M | 97.66% | -267.96% | -223.35% |